Product Information
ALOGLIPTIN 25 MG TABLET is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $4.8534 per EA under NDC 45802015065. Its NADAC has been published 519 times since Jul 20, 2016.
Strength
25 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802015065
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ALOGLIPTIN BENZOATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022271On Market Since
4/8/2016
Pharmacological Classes
Price Statistics
The NADAC for ALOGLIPTIN 25 MG TABLET has been published 519 times since Jul 20, 2016, and over the history we have for it it has declined 30.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.8534 per EA |
|---|---|
| All-time high | $7.0040 (Sep 14, 2016) |
| All-time low | $4.1779 (May 22, 2024) |
| 52-week high | $4.9869 |
| 52-week low | $4.5383 |
| Median price | $5.2497 |
| Average price | $5.3119 |
| Largest weekly change | +14.3% (Aug 21, 2024) |
| Weeks tracked | 519 |
| Tracking since | Jul 20, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Alogliptin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ALOGLIPTIN 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALOGLIPTIN 25 MG TABLET, manufactured by Padagis Israel Pharmaceuticals Ltd, is $4.8534 per EA (NDC 45802015065), effective Jun 24, 2026.
How has the price of ALOGLIPTIN 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALOGLIPTIN 25 MG TABLET has declined 30.7%. It has been tracked across 519 weekly CMS publications since Jul 20, 2016.
What are the highest and lowest recorded NADAC prices for ALOGLIPTIN 25 MG TABLET?
Since Jul 20, 2016, the NADAC for ALOGLIPTIN 25 MG TABLET has ranged from a low of $4.1779 (May 22, 2024) to a high of $7.0040 (Sep 14, 2016), with a median of $5.2497 per EA.
Are there cheaper alternatives to ALOGLIPTIN 25 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ALOGLIPTIN 25 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ALOGLIPTIN 25 MG TABLET?
ALOGLIPTIN 25 MG TABLET (NDC 45802015065) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification